会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • REMOTE TRANSMISSION OF ELECTROMAGNETIC SIGNALS INDUCING NANOSTRUCTURES AMPLIFIABLE INTO A SPECIFIC DNA SEQUENCE
    • 诱导可扩增成特定DNA序列的纳米结构的电磁信号的远程传输
    • WO2012142568A9
    • 2013-02-14
    • PCT/US2012033765
    • 2012-04-16
    • MONTAGNIER LUCLAVALLEE CLAUDEAISSA JAMAL
    • MONTAGNIER LUCLAVALLEE CLAUDEAISSA JAMAL
    • G01N33/48G01N27/00
    • C12Q1/6816B82Y15/00G01N37/005C12Q2565/607
    • A general method for identifying both known and unknown DNA sequences at the origin of EMS, including DNA sequences in the plasma of patients suffering of chronic diseases such as Alzheimer, Parkinson, multiple sclerosis, rheumatoid arthritis, and other similar diseases, disorders and conditions. The invention is based on the discovery that: (1) The nanostructures induced by DNA sequences in water or other dipole solutions can faithfully reflect the information contained in these sequences at dilutions which do not contain anymore of that DNA, as evidenced by the fact that it can be retranscribed into the same DNA sequence by the polymerases and reagents used in classical polymerase chain reaction (PCR); (2) this information can be transmitted at a distance in water or other dipole solutions by EMS emitted by the nanostructures; and (3) EMS signatures of nanostructures containing this information can be detected, stored, transmitted, transduced and imprinted in water or other dipole solutions.
    • 用于鉴定EMS起源的已知和未知DNA序列的一般方法,包括患有慢性疾病如阿尔茨海默氏病,帕金森病,多发性硬化症,类风湿性关节炎和其它类似疾病,病症和病症的患者的血浆中的DNA序列。 本发明是基于以下发现:(1)由DNA序列在水或其他偶极子溶液中诱导的纳米结构可以忠实地反映这些序列中包含的信息,其稀释度不再包含该DNA,如以下事实所证实的: 可以通过经典聚合酶链式反应(PCR)中使用的聚合酶和试剂将其转染到相同的DNA序列中; (2)该信息可以通过纳米结构发射的EMS在水或其他偶极子溶液中一定距离传输; 和(3)含有该信息的纳米结构的EMS签名可以被检测,存储,传输,转导和印在水或其他偶极子解决方案中。
    • 5. 发明申请
    • REMOTE TRANSMISSION OF ELECTROMAGNETIC SIGNALS INDUCING NANOSTRUCTURES AMPLIFIABLE INTO A SPECIFIC DNA SEQUENCE
    • 诱导可扩增成特定DNA序列的纳米结构的电磁信号的远程传输
    • WO2012142568A3
    • 2012-12-20
    • PCT/US2012033765
    • 2012-04-16
    • MONTAGNIER LUCLAVALLEE CLAUDEAISSA JAMAL
    • MONTAGNIER LUCLAVALLEE CLAUDEAISSA JAMAL
    • G01N33/48G01N27/00
    • C12Q1/6816B82Y15/00G01N37/005C12Q2565/607
    • A method for identifying both known and unknown DNA sequences at the origin of EMS, including DNA sequences in the plasma of patients suffering of chronic diseases, disorders and conditions. The method is based on the discovery that: (1) The nanostructures induced by DNA sequences in water or other dipole solutions can faithfully reflect the information contained in these sequences at dilutions which do not contain anymore of that DNA, as evidenced by the fact that it can be retranscribed into the same DNA sequence by the polymerases and reagents used in classical polymerase chain reaction (peR); (2) this information can be transmitted at a distance in water or other dipole solutions by EMS emitted by the nanostructures; and (3) EMS signatures of nanostructures containing this information can be detected, stored, transmitted, transduced and imprinted in water or other dipole solutions.
    • 一种用于鉴定EMS起源的已知和未知DNA序列的方法,包括患有慢性疾病,病症和病症的患者的血浆中的DNA序列。 该方法基于以下发现:(1)由水中或其他偶极子溶液中的DNA序列诱导的纳米结构可以忠实地反映这些序列中包含的信息,其稀释度不再包含该DNA,如以下事实所证实的: 它可以通过经典聚合酶链反应(peR)中使用的聚合酶和试剂转染到相同的DNA序列中; (2)该信息可以通过由纳米结构发射的EMS在水或其他偶极子溶液中一定距离传输; (3)含有该信息的纳米结构的EMS签名可以被检测,存储,传输,转导和印在水中或其他偶极子解决方案中。